{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T06:17:30Z","timestamp":1774851450730,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>During the 2019 coronavirus (COVID-19) pandemic, in-person medical visits changed due to social distancing guidelines. Breast cancer (BC) patients, needing ongoing treatment or surveillance, faced increased challenges in accessing care. Telehealth became essential for providing convenient and cost-effective care while minimizing COVID-19 transmission. BC survivors, however, often value in-person visits for clinical exams. This study aimed to compare telehealth participation between patients with a history of BC and women without cancer history.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Adults aged 18 and older, including cancer patients, survivors, caregivers, and healthy volunteers, primarily from Ohio, were recruited with attention and inclusion of underserved and minority populations to complete a survey about COVID-19-related beliefs, practices, and knowledge. Recruitment involved (1) re-contacting participants from previous OSU studies (2) outreach via community partners and listservs to invite additional participants and caregivers. Sociodemographic characteristics by BC status were calculated using Chi square tests. Univariable and multivariable logistic regressions modeled association between the outcome of interest, telehealth participation, and BC status accounting for race, ethnicity, age, education, marital status, rurality, and insurance status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The final sample included 2265 participants, with 43.7% having a history of BC. Significant demographic differences were observed between participants with and without a history of breast cancer. Those with a previous BC diagnosis were younger on average (55.6 vs. 57.9\u00a0years,\n                      <jats:italic>p\u2009&lt;<\/jats:italic>\n                      \u2009.001), had higher levels of educational attainment (\n                      <jats:italic>p\u2009&lt;<\/jats:italic>\n                      \u2009.001), were less often married and more often divorced\/widowed\/separated (\n                      <jats:italic>p\u2009=<\/jats:italic>\n                      \u2009.037), and were more likely to have private insurance only and less likely to have both public and private coverage (\n                      <jats:italic>p\u2009&lt;<\/jats:italic>\n                      \u2009.001). Telehealth use was lower during COVID-19 among BC survivors (41.5%) vs. those without cancer (63.9%) (\n                      <jats:italic>p\u2009&lt;<\/jats:italic>\n                      \u20090.001). In a multivariable model, factors that were statistically significantly associated with increased utilization of telehealth were Black race (OR\u2009=\u20091.90, p-value 0.036), having some college education (OR\u2009=\u20091.50, p-value 0.034), being married (OR\u2009=\u20091.61, p-value 0.009), and being currently employed (OR\u2009=\u20091.25, p-value 0.050). BC diagnosis or survivor status was associated with decreased odds of telehealth use (OR: 0.72,\n                      <jats:italic>p\u2009=<\/jats:italic>\n                      \u20090.023). Among breast cancer patients with complete data (n\u2009=\u2009645 of the 989 total), more than half used telehealth, with video visits being slightly more common than phone visits. Logistic regression analyses revealed increased telehealth use among patients with a history of BC was associated with age\u2009&gt;\u200970, while decreased participation in telehealth was associated with higher educational status and having undergone surgical treatment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We found that Black race, having some college education, being married, and being employed were significantly associated with increased telehealth participation during the COVID-19 pandemic. Interestingly, BC diagnosis was associated with reduced odds of telehealth use. Subgroup analyses of patients with a history of BC showed decreased use of telehealth to be associated with higher education and recent surgery for BC. Further investigation is needed to understand the acceptability and barriers to telehealth among BC survivors, as this modality continues to play an expanding role in oncology care delivery in the post-pandemic era.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10549-026-07940-6","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T09:52:10Z","timestamp":1774345930000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Telehealth utilization during the COVID-19 pandemic: comparing breast cancer survivors to non-cancer patients and implications for current practice"],"prefix":"10.1007","volume":"216","author":[{"given":"Lashez A.","family":"Hawkins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruvarashe P.","family":"Rumano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharnell S.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chloe M.","family":"Beverly-Hery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James L.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akia","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Champion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bridget A.","family":"Oppong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Electra D.","family":"Paskett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"7940_CR1","unstructured":"American Cancer Society. Breast Cancer Statistics | How Common Is Breast Cancer? www.cancer.org. Published January 17, 2024. https:\/\/www.cancer.org\/cancer\/types\/breast-cancer\/about\/how-common-is-breast-cancer.html#:~:text=At%20this%20time%20there%20are"},{"issue":"11","key":"7940_CR2","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1093\/jnci\/djab097","volume":"113","author":"O Alagoz","year":"2021","unstructured":"Alagoz O, Lowry KP, Kurian AW et al (2021) Impact of the COVID-19 pandemic on breast cancer mortality in the US: estimates from collaborative simulation modeling. J Natl Cancer Inst 113(11):1484\u20131494. https:\/\/doi.org\/10.1093\/jnci\/djab097","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"7940_CR3","doi-asserted-by":"publisher","first-page":"54","DOI":"10.7812\/tpp\/21.126","volume":"26","author":"A Tang","year":"2022","unstructured":"Tang A, Neeman E, Kuehner GE et al (2022) Telehealth for preoperative evaluation of patients with breast cancer during the COVID-19 pandemic. Perm J 26(2):54\u201363. https:\/\/doi.org\/10.7812\/tpp\/21.126","journal-title":"Perm J"},{"issue":"4","key":"7940_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.maturitas.2022.10.011","volume":"168","author":"A Garc\u00eda-Vigara","year":"2023","unstructured":"Garc\u00eda-Vigara A, Mart\u00edn-Gonz\u00e1lez V, Carbonell JA et al (2023) The COVID-19 pandemic and the usability of telehealth in a midlife women\u2019s health integrated care program. Maturitas 168(4):7\u201312. https:\/\/doi.org\/10.1016\/j.maturitas.2022.10.011","journal-title":"Maturitas"},{"key":"7940_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/ajo.13510","author":"EJ Mclaughlin","year":"2022","unstructured":"Mclaughlin EJ, Ellett LC, Readman E, Mooney S (2022) Telehealth for gynaecology outpatients during the COVID\u201019 pandemic: patient and clinician experiences. Aust N Z J Obstet Gynaecol. https:\/\/doi.org\/10.1111\/ajo.13510","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"2","key":"7940_CR6","doi-asserted-by":"publisher","DOI":"10.4258\/hir.2012.18.2.153","volume":"18","author":"S Ryu","year":"2012","unstructured":"Ryu S (2012) Telemedicine: opportunities and developments in member states: report on the second global survey on eHealth 2009 (Global Observatory for eHealth Series, Volume 2). Healthc Inform Res 18(2):153. https:\/\/doi.org\/10.4258\/hir.2012.18.2.153","journal-title":"Healthc Inform Res"},{"issue":"4","key":"7940_CR7","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.pop.2022.04.002","volume":"49","author":"J Shaver","year":"2022","unstructured":"Shaver J (2022) The state of telehealth before and after the COVID-19 pandemic. Prim Care 49(4):517\u2013530. https:\/\/doi.org\/10.1016\/j.pop.2022.04.002","journal-title":"Prim Care"},{"issue":"6","key":"7940_CR8","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1007\/s11764-022-01231-x","volume":"17","author":"BA Oppong","year":"2022","unstructured":"Oppong BA, Lustberg MB, Nolan TS et al (2022) Utilization of cancer survivorship services during the COVID-19 pandemic in a tertiary referral center. J Cancer Surviv 17(6):1708\u20131714. https:\/\/doi.org\/10.1007\/s11764-022-01231-x","journal-title":"J Cancer Surviv"},{"issue":"3","key":"7940_CR9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1188\/22.onf.223-231","volume":"49","author":"S Teicher","year":"2022","unstructured":"Teicher S, Whitney R, Liu R (2022) Breast cancer survivors\u2019 satisfaction and information recall of telehealth survivorship care plan appointments during the COVID-19 pandemic. Oncol Nurs Forum 49(3):223\u2013231. https:\/\/doi.org\/10.1188\/22.onf.223-231","journal-title":"Oncol Nurs Forum"},{"issue":"3","key":"7940_CR10","doi-asserted-by":"publisher","first-page":"e240131","DOI":"10.1001\/jamahealthforum.2024.0131","volume":"5","author":"FO Marcondes","year":"2024","unstructured":"Marcondes FO, Normand SLT, Le Cook B, Huskamp HA, Rodriguez JA, Barnett ML, Uscher-Pines L, Busch AB, Mehrotra A (2024) Racial and ethnic differences in telemedicine use. In JAMA Health Forum. 5(3):e240131\u2013e240131. https:\/\/doi.org\/10.1001\/jamahealthforum.2024.0131","journal-title":"In JAMA Health Forum."},{"key":"7940_CR11","doi-asserted-by":"publisher","unstructured":"Populations During the COVID-19 Pandemic: retrospective observational study. Journal of Medical Internet Research. 2023;25(25):e43604. https:\/\/doi.org\/10.2196\/436012","DOI":"10.2196\/436012"},{"key":"7940_CR12","doi-asserted-by":"publisher","unstructured":"Reported Access to Telehealth: An Important and Unmeasured Social Determinant of Health. JCO Oncology Practice. 2023;19(12). https:\/\/doi.org\/10.1200\/op.23.00006","DOI":"10.1200\/op.23.00006"},{"key":"7940_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s11764-021-01133-4","author":"PI Jewett","year":"2021","unstructured":"Jewett PI, Vogel RI, Ghebre R et al (2021) Telehealth in cancer care during COVID-19: disparities by age, race\/ethnicity, and residential status. J Cancer Surviv. https:\/\/doi.org\/10.1007\/s11764-021-01133-4","journal-title":"J Cancer Surviv"},{"issue":"12","key":"7940_CR14","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.ijmedinf.2014.08.011","volume":"83","author":"J Hofstede","year":"2014","unstructured":"Hofstede J, de Bie J, van Wijngaarden B, Heijmans M (2014) Knowledge, use and attitude toward eHealth among patients with chronic lung diseases. Int J Med Inform 83(12):967\u2013974. https:\/\/doi.org\/10.1016\/j.ijmedinf.2014.08.011","journal-title":"Int J Med Inform"},{"issue":"11","key":"7940_CR15","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1016\/s0277-9536(02)00546-4","volume":"57","author":"TJ Iwashyna","year":"2003","unstructured":"Iwashyna TJ, Christakis NA (2003) Marriage, widowhood, and health-care use. Soc Sci Med 57(11):2137\u20132147. https:\/\/doi.org\/10.1016\/s0277-9536(02)00546-4","journal-title":"Soc Sci Med"},{"issue":"6","key":"7940_CR16","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.jamcollsurg.2020.08.760","volume":"231","author":"MT Kemp","year":"2020","unstructured":"Kemp MT, Liesman DR, Brown CS et al (2020) Factors associated with increased risk of patient no-show in telehealth and traditional surgery clinics. J Am Coll Surg 231(6):695\u2013702. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2020.08.760","journal-title":"J Am Coll Surg"},{"key":"7940_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s13721-021-00300-y","author":"CA Clare","year":"2021","unstructured":"Clare CA (2021) Telehealth and the digital divide as a social determinant of health during the COVID-19 pandemic. Netw Model Anal Health Inform Bioinform. https:\/\/doi.org\/10.1007\/s13721-021-00300-y","journal-title":"Netw Model Anal Health Inform Bioinform"},{"issue":"3","key":"7940_CR18","doi-asserted-by":"publisher","first-page":"149","DOI":"10.7812\/tpp\/21.156","volume":"26","author":"P Sharma","year":"2022","unstructured":"Sharma P, Patten CA (2022) A need for digitally inclusive health care service in the United States: recommendations for clinicians and health care systems. Perm J 26(3):149\u2013153. https:\/\/doi.org\/10.7812\/tpp\/21.156","journal-title":"Perm J"},{"key":"7940_CR19","unstructured":"Office USGA. Telehealth in the Pandemic\u2014How Has It Changed Health Care Delivery in Medicaid and Medicare? www.gao.gov. Published September 29, 2022. https:\/\/www.gao.gov\/blog\/telehealth-pandemic-how-has-it-changed-health-care-delivery-medicaid-and-medicare#:~:text=To%20prevent%20the%20spread%20of"},{"key":"7940_CR20","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1245\/s10434-021-11103-w","volume":"29","author":"L Cadili","year":"2021","unstructured":"Cadili L, DeGirolamo K, Ma CSY et al (2021) The breast cancer patient experience of telemedicine during COVID-19. Ann Surg Oncol 29:2244\u20132252. https:\/\/doi.org\/10.1245\/s10434-021-11103-w","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"7940_CR21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/pds.5541","volume":"32","author":"GS Calip","year":"2023","unstructured":"Calip GS, Cohen A, Rohrer R et al (2023) Telemedicine use among patients with metastatic breast cancer during the COVID-19 pandemic: Differences by race, age, and region. Pharmacoepidemiol Drug Saf 32(1):66\u201372. https:\/\/doi.org\/10.1002\/pds.5541","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"28_suppl","key":"7940_CR22","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1200\/jco.2022.40.28_suppl.386","volume":"40","author":"D Kumar","year":"2022","unstructured":"Kumar D, Gordon NP, Neeman E et al (2022) Patient preferences for telehealth versus in-person oncology visits. J Clin Oncol 40(28_suppl):386\u2013386. https:\/\/doi.org\/10.1200\/jco.2022.40.28_suppl.386","journal-title":"J Clin Oncol"},{"issue":"2","key":"7940_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.apjon.2023.100360","volume":"11","author":"L Ren","year":"2024","unstructured":"Ren L, Chen M, Jiang H, Wang Y, Xia L, Dong C (2024) Perceptions of adult patients with cancer towards telemedicine: A qualitative meta-synthesis. Asia-Pac J Oncol Nurs 11(2):100360. https:\/\/doi.org\/10.1016\/j.apjon.2023.100360","journal-title":"Asia-Pac J Oncol Nurs"},{"key":"7940_CR24","volume-title":"Psychosocial needs of women with breast cancer","author":"M Hewitt","year":"2004","unstructured":"Board I of M (US), NRC (US) NCP, Hewitt M, Herdman R, Holland J (2004) Psychosocial needs of women with breast cancer. National Academies Press, US"},{"key":"7940_CR25","unstructured":"Alyafei A, Easton-Carr R. The health belief model of behavior change. [Updated 2024 May 19]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK606120\/26."},{"issue":"3","key":"7940_CR26","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10549-024-07379-727","volume":"207","author":"SY Atre","year":"2024","unstructured":"Atre SY, Soulos PR, Kuderer NM, Gross CP, Baum LVM, Dinan MA, Lustberg MB (2024) Characterization of time toxicity in older patients with metastatic breast cancer. Breast Cancer Res Treat 207(3):541\u2013550. https:\/\/doi.org\/10.1007\/s10549-024-07379-727","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"7940_CR27","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1093\/oncolo\/oyae18728","volume":"29","author":"A Gupta","year":"2024","unstructured":"Gupta A, Brundage MD, Galica J, Karim S, Koven R, Ng TL, O\u2019Donnell J, tenHove J, Robinson A, Booth CM (2024) Patients\u2019 considerations of time toxicity when assessing cancer treatments with marginal benefit. Oncologist 29(11):978\u2013985. https:\/\/doi.org\/10.1093\/oncolo\/oyae18728","journal-title":"Oncologist"},{"issue":"15","key":"7940_CR28","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1200\/JCO.21.02810","volume":"40","author":"A Gupta","year":"2022","unstructured":"Gupta A, Booth CM (2022) The time toxicity of cancer treatment. J Clin Oncol 40(15):1611\u20131615. https:\/\/doi.org\/10.1200\/JCO.21.02810","journal-title":"J Clin Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-026-07940-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-026-07940-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-026-07940-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T04:55:29Z","timestamp":1774846529000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-026-07940-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["7940"],"URL":"https:\/\/doi.org\/10.1007\/s10549-026-07940-6","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"assertion":[{"value":"14 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}